Key result
Marfan syndrome is linked to increased left atrial size and higher NT-proBNP independent of filling pressures.
Why the study?
Marfan syndrome variably affects the heart, but cardiac function with a specific focus on the left atrium required further investigation in this population.
Cross-Sectional (n=337)
No
Marfan syndrome is associated with primary structural and functional changes in the left atrium that appear to be independent of left ventricular dysfunction.
Answers are grounded in this paper and cite their sources.
Suggests primary LA involvement in Marfan syndrome; hypothesis-generating and should not yet change practice.
Marfan syndrome (MFS) is an autosomal-dominant multisystem connective tissue disorder that is based on mutations in the FBN1 gene and variably affects different organs, including the heart. In this study, we investigated cardiac function with a focus on the left atrium (LA) in a relatively large cohort of patients with MFS. After screening of 1165 patients that had been examined in our center between 2016 and 2020, 231 adult MFS patients with and without aortic operation were included in our study and compared to a healthy control group (n = 106). Cardiac function was assessed by transthoracic echocardiography and NT-proBNP was used as a secretory marker. Most (94.8%) of the patients received genetic testing. Left ventricular function was within normal ranges and not impaired. Interestingly, we found that LA size and secretory activity were increased in MFS patients, despite normal left ventricular filling pressures. This finding was even more pronounced in MFS patients with prior aortic surgery. A correlation between LA size or NT-proBNP levels and the type of pathogenic FBN1 variant could not be identified. Right ventricular function and right atrial size were increased only in MFS patients that had undergone aortic surgery. In conclusion, these findings suggest that MFS leads to structural changes in the LA that are not solely resulting from left ventricular dysfunction, but probably can be considered a primary pathology of MFS.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2023) conducted a cross-sectional in Marfan syndrome (n=337). Marfan syndrome vs. Healthy controls was evaluated on Left atrial size and secretory activity (NT-proBNP) (p=<0.05). Marfan syndrome was associated with significantly increased left atrial size and NT-proBNP levels compared to healthy controls, independent of left ventricular filling pressures.
Synapse has enriched 10 related papers. Consider them for comparative context: